000 01403 a2200397 4500
005 20250516042916.0
264 0 _c20120404
008 201204s 0 0 eng d
022 _a1876-1038
024 7 _a10.2174/157488711796575559
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMakri, Ira
245 0 0 _aSugammadex, a promising reversal drug. A review of clinical trials.
_h[electronic resource]
260 _bReviews on recent clinical trials
_cSep 2011
300 _a250-5 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClinical Trials as Topic
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aNeuromuscular Blockade
650 0 4 _aNeuromuscular Nondepolarizing Agents
_xantagonists & inhibitors
650 0 4 _aSugammadex
650 0 4 _agamma-Cyclodextrins
_xpharmacology
700 1 _aPapadima, Artemisia
700 1 _aLafioniati, Aimilia
700 1 _aPappas, Apostolos B
700 1 _aGeorge, Karanikas
700 1 _aNikolaos, Koronakis E
700 1 _aIoannis, Chrysikos D
700 1 _aCharalambos, Seretis
700 1 _aEmmanuel, Lagoudianakis E
700 1 _aXanthos, Theodoros
700 1 _aPapadimitriou, Lila
773 0 _tReviews on recent clinical trials
_gvol. 6
_gno. 3
_gp. 250-5
856 4 0 _uhttps://doi.org/10.2174/157488711796575559
_zAvailable from publisher's website
999 _c20937210
_d20937210